Elecsys tgab kit

The determination of TSH levels was carried out using an electrochemiluminescence immunoassay provided by Roche (Mannheim, Germany), with a detectable laboratory range spanning from 0.004 to 100 μIU/mL. The Tg level was assayed using the Elecsys® Tg II kit(Roche Diagnostics, Basilea, Switzerland), with a detection range of 0.04–500.00 ng/mL. The TgAb level was measured using the Elecsys® TgAb kit from Roche Diagnostics, and TgAb levels less than 115 IU/mL were considered negative. Tg was measured with the Elecsys® Tg II kit(Roche Diagnostics, Basilea, Switzerland), with a detection range of 0.04–500.00 ng/mL. Additionally, the TgAb level was assayed using the Elecsys® TgAb kit(Roche Diagnostics, Basilea, Switzerland). TgAb levels falling below 115 IU/mL were deemed negative. Genomic DNA was extracted from the primary tumors and subjected to traditional Sanger sequencing for the identification of BRAF^V600E mutations.The BRAF^V600E mutation status of primary PTC tumors was determined after surgery.